ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Designing synthetic superagonists of C3a anaphylatoxin

Cite this: Biochemistry 1991, 30, 15, 3603–3612
Publication Date (Print):April 16, 1991
    ACS Legacy Archive

    Article Views





    Other access options
    Supporting Info (1)»

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at

    Cited By

    This article is cited by 61 publications.

    1. Robert C. Reid, Mei-Kwan Yau, Ranee Singh, Johan K. Hamidon, Junxian Lim, Martin J. Stoermer, and David P. Fairlie . Potent Heterocyclic Ligands for Human Complement C3a Receptor. Journal of Medicinal Chemistry 2014, 57 (20) , 8459-8470.
    2. Meghan L. Bellows-Peterson, Ho Ki Fung, and Christodoulos A. Floudas , Chris A. Kieslich, Li Zhang, and Dimitrios Morikis , Kathryn J. Wareham and Peter N. Monk , Owen A. Hawksworth and Trent M. Woodruff . De Novo Peptide Design with C3a Receptor Agonist and Antagonist Activities: Theoretical Predictions and Experimental Validation. Journal of Medicinal Chemistry 2012, 55 (9) , 4159-4168.
    3. Conor C. G. Scully, Jade S. Blakeney, Ranee Singh, Huy N. Hoang, Giovanni Abbenante, Robert C. Reid and David P. Fairlie. Selective Hexapeptide Agonists and Antagonists for Human Complement C3a Receptor. Journal of Medicinal Chemistry 2010, 53 (13) , 4938-4948.
    4. Gloria Ruiz-Gómez, Joel D. A. Tyndall, Bernhard Pfeiffer, Giovanni Abbenante, and David P. Fairlie. Update 1 of: Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure. Chemical Reviews 2010, 110 (4) , PR1-PR41.
    5. Jade S. Blakeney,, Robert C. Reid,, Giang T. Le, and, David P. Fairlie. Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors. Chemical Reviews 2007, 107 (7) , 2960-3041.
    6. Joel D. A. Tyndall,, Bernhard Pfeiffer,, Giovanni Abbenante, and, David P. Fairlie. Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure. Chemical Reviews 2005, 105 (3) , 793-826.
    7. Shu‐Juan Zhao, Kun‐Yi Wu, Xiao‐Yun Min, Chun‐Xuan Wang, Bo Cao, Ning Ma, Xue‐Ling Yang, Zhuo‐Ran Zhu, Rong‐Guo Fu, Wuding Zhou, Ju‐Rong Yang, Ke Li. Protective role for C3aR in experimental chronic pyelonephritis. The FASEB Journal 2022, 36 (11)
    8. Chih-Lung Wu, Ya-Han Chih, Hsin-Ying Hsieh, Kuang-Li Peng, Yi-Zong Lee, Bak-Sau Yip, Shih-Che Sue, Jya-Wei Cheng. High Level Expression and Purification of Cecropin-like Antimicrobial Peptides in Escherichia coli. Biomedicines 2022, 10 (6) , 1351.
    9. Pei Qiao, Dalong Zhi, Chen Yu, Chen Zhang, Kunyi Wu, Hui Fang, Shuai Shao, Wen Yin, Erle Dang, Ke Li, Gang Wang. Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis. The FASEB Journal 2022, 36 (5)
    10. Farida El Gaamouch, Mickael Audrain, Wei-Jye Lin, Noam Beckmann, Cheng Jiang, Siddharth Hariharan, Peter S. Heeger, Eric E. Schadt, Sam Gandy, Michelle E. Ehrlich, Stephen R. Salton. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. Molecular Neurodegeneration 2020, 15 (1)
    11. Bhavani S. Sahu, Pedro Rodriguez, Megin E. Nguyen, Ruijun Han, Cheryl Cero, Maria Razzoli, Paolo Piaggi, Lauren J. Laskowski, Mihaela Pavlicev, Louis Muglia, Sushil K. Mahata, Scott O’Grady, John D. McCorvy, Leslie J. Baier, Yuk Y. Sham, Alessandro Bartolomucci. Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. Cell Reports 2019, 28 (10) , 2567-2580.e6.
    12. Kun-Yi Wu, Ting Zhang, Guo-Xiu Zhao, Ning Ma, Shu-Juan Zhao, Na Wang, Jia-Xing Wang, Zong-Fang Li, Wuding Zhou, Ke Li. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli–induced kidney injury in mice. Kidney International 2019, 96 (3) , 612-627.
    13. Marcel Muenstermann, Lea Strobel, Andreas Klos, Rick A. Wetsel, Trent M. Woodruff, Jörg Köhl, Kay O. Johswich. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. Virulence 2019, 10 (1) , 677-694.
    14. Bhavani S. Sahu, Ruijun Han, Cheryl Cero, Maria Razzoli, Pedro Rodriguez, Megin E. Nguyen, Paolo Piaggi, Mihaela Pavlicev, Louis Muglia, Sushil K. Mahata, Leslie Baier, Yuk Y. Sham, Alessandro Bartolomucci. Peptide/Receptor Evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. SSRN Electronic Journal 2019, 24
    15. Liam G. Coulthard, Owen A. Hawksworth, Jacinta Conroy, John D. Lee, Trent M. Woodruff. Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance. Molecular Immunology 2018, 101 , 176-181.
    16. Shalini Singh, Aritreyee Datta, Artur Schmidtchen, Anirban Bhunia, Martin Malmsten. Tryptophan end-tagging for promoted lipopolysaccharide interactions and anti-inflammatory effects. Scientific Reports 2017, 7 (1)
    17. Hui-Yuan Yu, Yi-An Chen, Bak-Sau Yip, Siou-Ying Wang, Hsiu-Ju Wei, Ya-Han Chih, Kuan-Hao Chen, Jya-Wei Cheng. Role of β-naphthylalanine end-tags in the enhancement of antiendotoxin activities: Solution structure of the antimicrobial peptide S1-Nal-Nal in complex with lipopolysaccharide. Biochimica et Biophysica Acta (BBA) - Biomembranes 2017, 1859 (6) , 1114-1123.
    18. Cheryl Cero, Maria Razzoli, Ruijun Han, Bhavani Shankar Sahu, Jessica Patricelli, ZengKui Guo, Nathan A. Zaidman, John M. Miles, Scott M. O'Grady, Alessandro Bartolomucci. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis. Molecular Metabolism 2017, 6 (1) , 148-158.
    19. Laure Yatime, Goran Bajic, Janus Asbjørn Schatz-Jakobsen, Gregers Rom Andersen. Complement Regulators and Inhibitors in Health and Disease: A Structural Perspective. 2016, 13-42.
    20. Reena Halai, Meghan L Bellows-Peterson, Will Branchett, James Smadbeck, Chris A Kieslich, Daniel E Croker, Matthew A Cooper, Dimitrios Morikis, Trent M Woodruff, Christodoulos A Floudas, Peter N Monk. Derivation of ligands for the complement C3a receptor from the C-terminus of C5a. European Journal of Pharmacology 2014, 745 , 176-181.
    21. Kathryn E. Lillegard, Alex C. Loeks-Johnson, Jonathan W. Opacich, Jenna M. Peterson, Ashley J. Bauer, Barbara J. Elmquist, Ronald R. Regal, Jeffrey S. Gilbert, Jean F. Regal. Differential Effects of Complement Activation Products C3a and C5a on Cardiovascular Function in Hypertensive Pregnant Rats. Journal of Pharmacology and Experimental Therapeutics 2014, 351 (2) , 344-351.
    22. Mike C. L. Wu, Faith H. Brennan, Jason P. L. Lynch, Susanna Mantovani, Simon Phipps, Rick A. Wetsel, Marc J. Ruitenberg, Stephen M. Taylor, Trent M. Woodruff. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proceedings of the National Academy of Sciences 2013, 110 (23) , 9439-9444.
    23. Andreas Klos, Elisabeth Wende, Kathryn J. Wareham, Peter N. Monk. International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors. Pharmacological Reviews 2013, 65 (1) , 500-543.
    24. Sakeen W. Kashem, Hariharan Subramanian, Sarah J. Collington, Paola Magotti, John D. Lambris, Hydar Ali. G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: Roles of Mas-related genes MrgX1 and MrgX2. European Journal of Pharmacology 2011, 668 (1-2) , 299-304.
    25. Lavinia M. Proctor, Tyson A. Moore, Peter N. Monk, Sam D. Sanderson, Stephen M. Taylor, Trent M. Woodruff. Complement factors C3a and C5a have distinct hemodynamic effects in the rat. International Immunopharmacology 2009, 9 (6) , 800-806.
    26. Artur Schmidtchen, Mukesh Pasupuleti, Matthias Mörgelin, Mina Davoudi, Jan Alenfall, Anna Chalupka, Martin Malmsten. Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags. Journal of Biological Chemistry 2009, 284 (26) , 17584-17594.
    27. Mukesh Pasupuleti, Artur Schmidtchen, Anna Chalupka, Lovisa Ringstad, Martin Malmsten, . End-Tagging of Ultra-Short Antimicrobial Peptides by W/F Stretches to Facilitate Bacterial Killing. PLoS ONE 2009, 4 (4) , e5285.
    28. Peter Monk. C3a Chemotactic Peptide Receptor. 2007, 1-6.
    29. Jinming Gao, Hyeryun Choe, Dalena Bota, Paulette L. Wright, Craig Gerard, Norma P. Gerard. Sulfation of Tyrosine 174 in the Human C3a Receptor Is Essential for Binding of C3a Anaphylatoxin. Journal of Biological Chemistry 2003, 278 (39) , 37902-37908.
    30. Weiyuan John Kao. Evaluation of leukocyte adhesion on polyurethanes: the effects of shear stress and blood proteins. Biomaterials 2000, 21 (22) , 2295-2303.
    31. Holger Petering, Jörg Köhl, Ansgar Weyergraf, Yasmin Dulkys, Daniela Kimmig, Regina Smolarski, Alexander Kapp, Jörn Elsner. Characterization of Synthetic C3a Analog Peptides on Human Eosinophils in Comparison to the Native Complement Component C3a. The Journal of Immunology 2000, 164 (7) , 3783-3789.
    32. Mark A Jagels, Pamela J Daffern, Tony E Hugli. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 2000, 46 (3) , 209-222.
    33. Weiyuan John Kao. Evaluation of protein-modulated macrophage behavior on biomaterials: designing biomimetic materials for cellular engineering. Biomaterials 1999, 20 (23-24) , 2213-2221.
    34. Yoshihiro Fukuoka, Julia A. Ember, Tony E. Hugli. Ligand Binding Sites on Guinea Pig C3aR: Point and Deletion Mutations in the Large Extracellular Loop and Vicinity. Biochemical and Biophysical Research Communications 1999, 263 (2) , 357-360.
    35. Pamela J. Daffern, Mark A. Jagels, Tony E. Hugli. Multiple Epithelial Cell–Derived Factors Enhance Neutrophil Survival. American Journal of Respiratory Cell and Molecular Biology 1999, 21 (2) , 259-267.
    36. Ta-Hsiang Chao, Julia A. Ember, Meiying Wang, Yolanda Bayon, Tony E. Hugli, Richard D. Ye. Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function. Journal of Biological Chemistry 1999, 274 (14) , 9721-9728.
    37. Torsten Crass, Robert S. Ames, Henry M. Sarau, Mark A. Tornetta, James J. Foley, Jörg Köhl, Andreas Klos, Wilfried Bautsch. Chimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88). Journal of Biological Chemistry 1999, 274 (13) , 8367-8370.
    38. Wolfgang H. Fischer, Mark A. Jagels, Tony E. Hugli. Regulation of IL-6 Synthesis in Human Peripheral Blood Mononuclear Cells by C3a and C3adesArg. The Journal of Immunology 1999, 162 (1) , 453-459.
    39. Jianzhong Sun, Julia A. Ember, Ta‐Hsiang Chao, Tony E. Hugli, Yoshihiro Fukuoka, Richard D. Ye. Identification of ligand effector binding sites in transmembrane regions of the human G protein‐coupled C3a receptor. Protein Science 1999, 8 (11) , 2304-2311.
    40. Yoshihiro Fukuoka, Julia A. Ember, Tony E. Hugli. Molecular Cloning of Two Isoforms of the Guinea Pig C3a Anaphylatoxin Receptor: Alternative Splicing in the Large Extracellular Loop . The Journal of Immunology 1998, 161 (6) , 2977-2984.
    41. Stefan Lienenklaus, Robert S. Ames, Mark A. Tornetta, Henry M. Sarau, James J. Foley, Torsten Crass, Bettina Sohns, Ute Raffetseder, Melanie Grove, Anja Hölzer, Andreas Klos, Jörg Köhl, Wilfried Bautsch. Cutting Edge: Human Anaphylatoxin C4a Is a Potent Agonist of the Guinea Pig But Not the Human C3a Receptor . The Journal of Immunology 1998, 161 (5) , 2089-2093.
    42. Weiyuan John Kao, Jeffrey A. Hubbell. Murine macrophage behavior on peptide-grafted polyethyleneglycol-containing networks. Biotechnology and Bioengineering 1998, 59 (1) , 2-9.<2::AID-BIT2>3.0.CO;2-G
    43. Julia Ember, Mark Jagels, Tony Hugli. Characterization of Complement Anaphylatoxins and Their Biological Responses. 1998, 241-284.
    44. Clemens A. Dahinden. Anaphylatoxins. 1998, 86-91.
    45. Robert S. Ames, Mark A. Tometta, James J. Foley, Tony E. Hugli, Henry M. Sarau. Evidence that the receptor for C4a is distinct from the C3a receptor. Immunopharmacology 1997, 38 (1-2) , 87-92.
    46. Julia A. Ember, Tony E. Hugli. Complement factors and their receptors. Immunopharmacology 1997, 38 (1-2) , 3-15.
    47. Masakazu Takahashi, Shigeo Moriguchi, Hiroyuki Suganuma, Akira Shiota, Fumito Tani, Hachiro Usui, Kazuyoshi Kurahashi, Ryuzo Sasaki, Masaaki Yoshikawa. Identification of Casoxin C, An Ileum-contracting Peptide Derived From Bovine κ -casein, as an Agonist for C3a Receptors. Peptides 1997, 18 (3) , 329-336.
    48. Robert S Ames, Paru Nuthulaganti, Chandrika Kumar. In Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxins. FEBS Letters 1996, 395 (2-3) , 157-159.
    49. Robert S. Ames, Yi Li, Henry M. Sarau, Paru Nuthulaganti, James J. Foley, Catherine Ellis, Zhizhen Zeng, Kui Su, Anthony J. Jurewicz, Robert P. Hertzberg, Derk J. Bergsma, Chandrika Kumar. Molecular Cloning and Characterization of the Human Anaphylatoxin C3a Receptor. Journal of Biological Chemistry 1996, 271 (34) , 20231-20234.
    50. K. E. Foreman, M. M. Glovsky, R. L. Warner, S. J. Horvath, P. A. Ward. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 1996, 20 (1) , 1-9.
    51. Masakazu Takahashi, Shigeo Moriguchi, Masayuki Ikeno, Shigekatsu Kono, Katsuya Ohata, Hachiro Usui, Kazuyoshi Kurahashi, Ryuzo Sasaki, Masaaki Yoshikawa. Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin. Peptides 1996, 17 (1) , 5-12.
    52. Yoshihiro Fukuoka, Takehiko Tachibana, Akira Yasui. Anaphylatoxin C3a induces rapid protein phosphorylation in guinea pig platelets. Immunopharmacology 1994, 28 (2) , 95-104.
    53. Yoshihiro Fukuoka, Takehiko Tachibana, Akira Yasui. Expression of biologically active C3a as fusion proteins. Immunology Letters 1993, 38 (2) , 153-158.
    54. David F. Carney, Tony E. Hugli. Site‐specific mutations in the N‐terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor. Protein Science 1993, 2 (9) , 1391-1399.
    55. MARTINA POHLS, DOROTHEE AMBROSIUS, JOACHIM GRÖTZINGER, TITUS KRETZSCHMAR, DEREK SAUNDERS, AXEL WOLLMER, DIETRICH BRANDENBURG, DIETER BITTER‐SUERMANN, HARTWIG HÖCKER. Cyclic disulfide analogues of the complement component C3a Synthesis and conformational investigations. International Journal of Peptide and Protein Research 1993, 41 (4) , 362-375.
    56. Jörg Köhl, Bettina Lübbers, Andreas Klos, Wilfried Bautsch, Monika Casaretto. Evaluation of the C‐terminal C5a effector site with short synthetic C5a analog peptides. European Journal of Immunology 1993, 23 (3) , 646-652.
    57. S. K. Alex Law. Complement Receptors. 1993, 223-259.
    58. J. Köhl, D. Bitter-Suermann. Anaphylatoxins. 1993, 299-324.
    59. M. Federwisch, M. Casaretto, R. Gerardy-Schahn, D. Bitter-Suermann, A. Wollmer. Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study. Biophysical Chemistry 1992, 44 (3) , 151-161.
    60. William K. Hagmann, Robert D. Sindelar. Chapter 21. Potentlal Therapeutic Modifiers of the Complement Cascade. 1992, 199-208.
    61. Christodoulos A. Floudas, Ho Ki Fung, Dimitrios Morikis, Martin S. Taylor, Li Zhang. Overcoming the Key Challenges in De Novo Protein Design: Enhancing Computational Efficiency and Incorporating True Backbone Flexibility. , 133-183.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect